BioCardia (BCDA)
(Delayed Data from NSDQ)
$4.62 USD
-0.58 (-11.15%)
Updated May 31, 2024 04:00 PM ET
After-Market: $4.62 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Brokerage Reports
0 items in cart
BioCardia, Inc. [BCDA]
Reports for Purchase
Showing records 41 - 57 ( 57 total )
Company: BioCardia, Inc.
Industry: Medical - Drugs
Company: BioCardia, Inc.
Industry: Medical - Drugs
Too Cheap to Ignore ? Multiple Clinical Programs in Heart Failure and Business Deal Potential too.
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: BioCardia, Inc.
Industry: Medical - Drugs
Not All Cardiac Cell Therapies Are Created Equal; Initiating With a Buy Rating and $9 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: BioCardia, Inc.
Industry: Medical - Drugs
Slow Enrollment is Dragging Out Timelines. BioCardia Spends $2.7M in 3Q and Ends the Period with $16M
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: BioCardia, Inc.
Industry: Medical - Drugs
Company: BioCardia, Inc.
Industry: Medical - Drugs
DSMB Says OK to Continue - We Remain Neutral
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: BioCardia, Inc.
Industry: Medical - Drugs
Lowering from Buy to Neutral; Higher Dilution & A Short Runway - Expect Another Capital Raise
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: BioCardia, Inc.
Industry: Medical - Drugs
BUY: Chief Medical Officer Resigns; Lowering Price Target to $5.00 from $14.00
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: BioCardia, Inc.
Industry: Medical - Drugs
BUY: Chief Medical Officer Resigns; Lowering Price Target to $5.00 from $14.00
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: BioCardia, Inc.
Industry: Medical - Drugs
Company: BioCardia, Inc.
Industry: Medical - Drugs
Company: BioCardia, Inc.
Industry: Medical - Drugs
Company: BioCardia, Inc.
Industry: Medical - Drugs
Company: BioCardia, Inc.
Industry: Medical - Drugs
BUY: Building a Unique Cell Therapy Product and Company, A Tale of Two Products Allo - Auto
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: BioCardia, Inc.
Industry: Medical - Drugs
Company: BioCardia, Inc.
Industry: Medical - Drugs
Reports the Quarter with an Interesting IP item
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: BioCardia, Inc.
Industry: Medical - Drugs
Regenerative Medicine-The Best of Both Worlds
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J